COVID-19 vaccination in Vietnam
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.
Number of administered second doses (by percentage of total population):
20-40%
41-60%
61-80%
81-90%
91-100% | |
Date | March 8, 2021 – present |
---|---|
Location | Vietnam |
Cause | COVID-19 pandemic in Vietnam |
Target | Immunization against COVID-19 |
Budget | 25.2 trillion VND ($1.1 billion USD) |
Organised by | Vietnam's Ministry of Health |
Participants | 90,272,853 people with at least one dose administered of COVID-19 vaccine.
85,961,564 people have been fully vaccinated. |
Outcome | 91.94 percent of the Vietnamese population has received at least one dose.
87.55 percent of the Vietnamese population is fully vaccinated. |
Part of a series on the |
COVID-19 pandemic |
---|
|
COVID-19 portal |
This is the country's largest-ever immunization campaign, aiming to administer over 150 million doses. As of 6 April 2022, Vietnam has administered 207,235,119 vaccine doses across the country.